ATE223384T1 - Substituierte imidazoliunsalze und deren verwendung zur hemmung der proteinalterung - Google Patents

Substituierte imidazoliunsalze und deren verwendung zur hemmung der proteinalterung

Info

Publication number
ATE223384T1
ATE223384T1 AT97922635T AT97922635T ATE223384T1 AT E223384 T1 ATE223384 T1 AT E223384T1 AT 97922635 T AT97922635 T AT 97922635T AT 97922635 T AT97922635 T AT 97922635T AT E223384 T1 ATE223384 T1 AT E223384T1
Authority
AT
Austria
Prior art keywords
imidazoliun
salts
substituted
inhibiting
inhibiting protein
Prior art date
Application number
AT97922635T
Other languages
English (en)
Inventor
Dilip R Wagle
San-Bao Hwang
Veronica M Mallon
Sara Vasan
John J Egan
Peter Ulrich
Anthony Cerami
Original Assignee
Alteon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alteon Inc filed Critical Alteon Inc
Application granted granted Critical
Publication of ATE223384T1 publication Critical patent/ATE223384T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/762—Organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/771—Organic compounds containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT97922635T 1996-05-08 1997-05-02 Substituierte imidazoliunsalze und deren verwendung zur hemmung der proteinalterung ATE223384T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64328896A 1996-05-08 1996-05-08
US84877697A 1997-05-01 1997-05-01
PCT/US1997/007466 WO1997042175A1 (en) 1996-05-08 1997-05-02 Substituted imidazolium salts and their use for the inhibition of protein ageing

Publications (1)

Publication Number Publication Date
ATE223384T1 true ATE223384T1 (de) 2002-09-15

Family

ID=27094226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97922635T ATE223384T1 (de) 1996-05-08 1997-05-02 Substituierte imidazoliunsalze und deren verwendung zur hemmung der proteinalterung

Country Status (8)

Country Link
EP (2) EP0920418B1 (de)
JP (1) JP2002515033A (de)
AT (1) ATE223384T1 (de)
AU (1) AU724319B2 (de)
CA (1) CA2253788A1 (de)
DE (1) DE69715218T2 (de)
ES (1) ES2183171T3 (de)
WO (1) WO1997042175A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001052847A1 (en) * 2000-01-19 2001-07-26 Alteon, Inc. Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
WO2002053161A1 (en) 2000-12-29 2002-07-11 Alteon, Inc. Method for treating fibrotic diseases or other indications
ES2243389T3 (es) * 2001-03-21 2005-12-01 Torrent Pharmaceuticals Ltd Compuestos de piridinio utiles para el tratamiento de enfermedades relacionadas con los age.
FR2984733B1 (fr) * 2011-12-22 2016-09-30 Oreal Association d'un agent nucleophile et d'un agent azote ou phosphore de pka superieur a 11 pour la peau glyquee

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983604A (en) * 1987-11-13 1991-01-08 The Rockefeller University Inhibitors of nonenzymatic cross-linking
US5358960A (en) * 1984-03-19 1994-10-25 The Rockefeller University Method for inhibiting advanced glycosylation of proteins using aminosubstituted imidazoles
US5258381A (en) * 1984-03-19 1993-11-02 The Rockefeller University 2-substituted-2-imidazolines
US5514676A (en) * 1984-03-19 1996-05-07 The Rockefeller University Amino-benzoic acids and derivatives, and methods of use
US5221683A (en) * 1984-03-19 1993-06-22 The Rockefeller University Diaminopyridine compounds and methods of use
US5356895A (en) * 1984-03-19 1994-10-18 The Rockefeller University 1,4 piperizino inhibitors of non-enzymatic cross-linking of proteins

Also Published As

Publication number Publication date
CA2253788A1 (en) 1997-11-13
EP0920418A1 (de) 1999-06-09
DE69715218T2 (de) 2003-03-06
JP2002515033A (ja) 2002-05-21
DE69715218D1 (de) 2002-10-10
AU2825897A (en) 1997-11-26
AU724319B2 (en) 2000-09-14
EP1213282A1 (de) 2002-06-12
WO1997042175A1 (en) 1997-11-13
EP0920418B1 (de) 2002-09-04
ES2183171T3 (es) 2003-03-16

Similar Documents

Publication Publication Date Title
ATE245420T1 (de) Verwendung von thiazoliumverbindungen zum verhindern und umkehren der bildung von endprodukten der fortgeschrittenen glykosylierung
ATE388704T1 (de) Umkehrung der fortgeschrittenen glycosylierungsvernetzungen durch verwendung von heterozyklisch substituierten thiazoliumsalzen
DE3650080D1 (de) Verfahren und Mittel zur Hemmung des Proteinveraltens.
WO1993014750A3 (en) Amino acids useful as inhibitors of the advanced glycosylation of proteins
ES2174132T3 (es) N-acil-a,omp-alquil-hidrazino-carboximidamidas.
EP0316852A3 (de) Hemmer von nichtenzymatischer Quervernetzung
WO1999006545A8 (en) Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
ATE260099T1 (de) Neue hemmern von fortgeschrittenen glykosilierung-endprodukten
EP1159952A4 (de) Kosmetische zubereitungen
FI844817L (fi) Dispergeringsmedel foer salthaltiga system.
DE69533987D1 (de) Protein oder polypeptid, verfahren zur seiner herstellung und entsprechende zwischenprodukte
ATE227341T1 (de) Trimerisierende polypeptide, deren herstellung und verwendung
DE69627806D1 (de) Mayonnaiseähnliches Produkt und Verfahren zur Herstellung desselben
IL149843A0 (en) Method of treating hair loss using thyromimetic compounds
ATE354363T1 (de) Kombination von drei substanzen zur vorbeugung und behandlung von arthritis
ATE361064T1 (de) Neue inhibitoren der bildung der fortgeschrittenen glykosylierungsendprodukte
DE602004032345D1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
DE69715218D1 (de) Substituierte imidazoliunsalze und deren verwendung zur hemmung der proteinalterung
WO1996021450A3 (en) Bis-[hydrazones]
DE69732857D1 (de) Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen
ATE231845T1 (de) 1,2,4-triazinderivate zur inhibierung der proteinglycosylierung
WO1997042175B1 (en) Substituted imidazolium salts and their use for the inhibition of protein ageing
DE602004020962D1 (de) Sojaproteinkonzentrat mit hoher Gelfestigkeit und Verfahren zur Herstellung
ATE255989T1 (de) Verwendung einer enzymatischen zusammensetzung und verfahren zur affinage von frischem holz
Custer PARTIAL CHARACTERIZATION OF AN INHIBITOR OF BACTERIAL SPORE OUTGROWTH THAT IS THERMALLY DERIVED FROM NITRITE AND THE FORMATION OF ANALOGOUS INHIBITORS FROM LACTOFERRIN OR TRANSFERRIN FRAGMENTS AND NITRITE.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties